Evidence map›Paper›PMID 42567856›Full record

ArticleNature communications2026

Vitamin B

Jonathan Kölschbach, Hormos S Dafsari, Emily Baum, Anna Löhrke, Chun Kew, Ivan Dikic, Wenming Huang, Adam Antebi

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jonathan KölschbachMax Planck Institute for Biology of Ageing, Cologne, Germany.ORCID 0009-0000-5191-4732
Hormos S DafsariMax Planck Institute for Biology of Ageing, Cologne, Germany.ORCID 0000-0003-3483-5009
Emily BaumMax Planck Institute for Biology of Ageing, Cologne, Germany.
Anna LöhrkeMax Planck Institute for Biology of Ageing, Cologne, Germany.
Chun KewBuchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany.
Ivan DikicBuchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany.ORCID 0000-0001-8156-9511
Wenming HuangMax Planck Institute for Biology of Ageing, Cologne, Germany. whuang@age.mpg.de.ORCID 0000-0001-5252-3928
Adam AntebiMax Planck Institute for Biology of Ageing, Cologne, Germany. aantebi@age.mpg.de.ORCID 0000-0002-7241-3029

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

mRNA splicing represents a fundamental level of gene regulation that alters proteomic diversity and cellular state. Its dysfunction can profoundly rewire metabolism, yet underlying mechanisms remain elusive. Here, we investigate Verheij syndrome, caused by mutations in core splicing factor PUF60, using a Caenorhabditis elegans model, human cell lines, and patient-derived samples. We demonstrate that RNP-6/PUF60 deficiency disrupts splicing of genes governing one-carbon metabolism and phospholipid remodeling, impairing S-adenosylmethionine/S-adenosylhomocysteine cycling and phosphatidylcholine synthesis. These perturbations trigger the integrated stress response and compromise mTORC1 signaling, causing developmental growth defects. Vitamin B

Indexed as

PhospholipidsRNA SplicingVitamin B 12AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsHumansMechanistic Target of Rapamycin Complex 1MutationRNA Splicing FactorsS-AdenosylmethionineCaenorhabditis elegans ProteinsMechanistic Target of Rapamycin Complex 1PhospholipidsRNA Splicing FactorsS-AdenosylmethionineVitamin B 12

Identifiers

PMID42567856
PMCPMC13451374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.